MORRISVILLE, N.C., 2020年5月22日 (GLOBE NEWSWIRE) -- Syneos Health^® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (コマーシャルビジネス受託機関), today announced that Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs are scheduled to present at two upcoming investor conferences:

• Jefferies Virtual Healthcare Conference on 水曜日, 6月 3, 2020, at 9:30 a.m. ET.
• William Blair 40^th Annual Growth Stock Conference on 火曜日, 6月 9, 2020, at 9:00 a.m. ET.

A live webcast of each event, along with a link to the presentation materials and archived audio replay of each presentation, will be available on the Company’s Investor Relations website at investor.syneoshealth.com.

About Syneos Health
Syneos Health^® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and コマーシャルビジネス受託機関 (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. 弊社は一丸となって、洞察を共有し、最新技術を活用し、高度なビジネスプラクティスを応用して、お客様の重要な治療法を患者様にお届けする期間を短縮します。To learn more about how we are shortening the distance from lab to life^®, visit syneoshealth.com or subscribe to our podcast.

Contacts

Investor Relations:
Ronnie Speight
Senior Vice President, Investor Relations
+1 919 745 2745
[email protected]

Press/Media:
Danielle DeForge
Executive Director, External Communications
+1 202 210 5992
[email protected]

Source: Syneos Health, Inc.